The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine

Biomaterials

Volumn 32, Issue 18, 2011, Pages 4211-4214

  Barker, Thomas H ^a,b  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cell adhesion; Extracellular matrix; Integrin binding; RGD; Synthetic adhesion peptides

Indexed keywords

BINDING AFFINITIES; CELL BEHAVIORS; CELLULAR BEHAVIORS; ECM PROTEINS; ENVIRONMENTALLY SENSITIVE; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX; FUNCTIONAL TISSUE; INTEGRATED PROCESS; INTEGRIN BINDING; INTEGRINS; MATRIX; PROTEIN FRAGMENTS; RECEPTOR BINDING; REGENERATIVE MEDICINE; RGD; SPATIAL PERIODICITY; SYNTHETIC ADHESION PEPTIDES; SYNTHETIC PEPTIDE; TISSUE REGENERATION;

BINDING ENERGY; CELL ADHESION; CELLS; CHEMICAL MODIFICATION; DESIGN; PEPTIDES; TISSUE; TISSUE ENGINEERING;

ADHESION;

COLLAGEN; FIBRONECTIN; INTEGRIN; LAMININ; LIGAND; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN;

ARTICLE; BINDING SITE; CELL FUNCTION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; CELL ADHESION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIGANDS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; REGENERATIVE MEDICINE;

EID: 79955120631     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.027     Document Type: Article

References (43)

1. Schenk S., Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 2003, 13(7):366-375.
2. Metcalfe A.D., Ferguson M.W. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 2007, 4(14):413-437.
3. Miner J.H., Yurchenco P.D. Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004, 20:255-284.
4. Litjens S.H., de Pereda J.M., Sonnenberg A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol 2006, 16(7):376-383.
5. Kim J.M., Park W.H., Min B.M. The PPFLMLLKGSTR motif in globular domain 3 of the human laminin-5 alpha3 chain is crucial for integrin alpha3beta1 binding and cell adhesion. Exp Cell Res 2005, 304(1):317-327.
6. Nguyen B.P., Gil S.G., Carter W.G. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J Biol Chem 2000, 275(41):31896-31907.
7. Goldfinger L.E., Hopkinson S.B., deHart G.W., Collawn S., Couchman J.R., Jones J.C. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 1999, 112(Pt 16):2615-2629.
8. Hintermann E., Bilban M., Sharabi A., Quaranta V. Inhibitory role of alpha 6 beta 4-associated erbB-2 and phosphoinositide 3-kinase in keratinocyte haptotactic migration dependent on alpha 3 beta 1 integrin. J Cell Biol 2001, 153(3):465-478.
9. Nguyen B.P., Ryan M.C., Gil S.G., Carter W.G. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol 2000, 12(5):554-562.
10. O'Toole E.A., Marinkovich M.P., Hoeffler W.K., Furthmayr H., Woodley D.T. Laminin-5 inhibits human keratinocyte migration. Exp Cell Res 1997, 233(2):330-339.
11. Lee S.H., Moon J.J., West J.L. Three-dimensional micropatterning of bioactive hydrogels via two-photon laser scanning photolithography for guided 3D cell migration. Biomaterials 2008, 29(20):2962-2968.
12. Moon J.J., Hahn M.S., Kim I., Nsiah B.A., West J.L. Micropatterning of poly(ethylene glycol) diacrylate hydrogels with biomolecules to regulate and guide endothelial morphogenesis. Tissue Eng Part A 2009, 15(3):579-585.
13. Lee D., Khaja S., Velasquez-Castano J.C., Dasari M., Sun C., Petros J., et al. In vivo imaging of hydrogen peroxide with chemiluminescent nanoparticles. Nat Mater 2007, 6(10):765-769.
14. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A 2003, 100(9):5413-5418.
15. Salinas C.N., Anseth K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 2008, 29(15):2370-2377.
16. Mao Y., Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005, 24(6):389-399.
17. Pankov R.Y.K. Fibronectin at a glance. J Cell Sci 2002, 115(20):3861-3863.
18. Krammer A., Craig D., Thomas W.E., Schulten K., Vogel V. A structural model for force regulated integrin binding to fibronectin's RGD-synergy site. Matrix Biol 2002, 21(2):139-147.
19. Grant R.P., Spitzfaden C., Altroff H., Campbell I.D., Mardon H.J. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem 1997 Mar 7, 272(10):6159-6166.
20. Altroff H., Schlinkert R., van der Walle C.F., Bernini A., Campbell I.D., Werner J.M., et al. Interdomain tilt angle determines integrin-dependent function of the ninth and tenth FIII domains of human fibronectin. J Biol Chem 2004, 279(53):55995-56003.
21. Khew S.T., Zhu X.H., Tong Y.W. An integrin-specific collagen-mimetic peptide approach for optimizing Hep3B liver cell adhesion, proliferation, and cellular functions. Tissue Eng 2007, 13(10):2451-2463.
22. Gronthos S., Simmons P.J., Graves S.E., Robey P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001, 28(2):174-181.
23. Stephansson S.N., Byers B.A., Garcia A.J. Enhanced expression of the osteoblastic phenotype on substrates that modulate fibronectin conformation and integrin receptor binding. Biomaterials 2002, 23(12):2527-2534.
24. Koistinen P., Pulli T., Uitto V.J., Nissinen L., Hyypia T., Heino J. Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis. Matrix Biol 1999, 18(3):239-251.
25. Cheng S.L., Lai C.F., Blystone S.D., Avioli L.V. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3. J Bone Miner Res 2001, 16(2):277-288.
26. Garcia A.J., Vega M.D., Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 1999, 10(3):785-798.
27. Petrie T.A., Capadona J.R., Reyes C.D., Garcia A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 2006, 27(31):5459-5470.
28. Petrie T.A., Raynor J.E., Reyes C.D., Burns K.L., Collard D.M., Garcia A.J. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 2008, 29(19):2849-2857.
29. Martino M.M., Mochizuki M., Rothenfluh D.A., Rempel S.A., Hubbell J.A., Barker T.H. Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability. Biomaterials 2009, 30(6):1089-1097.
30. Barker T.H., Brown A.C., Rowe J. Guiding epithelial cell phenotypes with engineered integrin specific recombinant fibronectin fragments. Tissue Eng Part A 2011, 17(1-2):139-150.
31. Benoit D.S., Anseth K.S. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 2005, 26(25):5209-5220.
32. Davis G.E., Bayless K.J., Davis M.J., Meininger G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 2000, 156(5):1489-1498.
33. Mott J.D., Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004, 16(5):558-564.
34. Tran K.T., Lamb P., Deng J.S. Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 2005, 40(1):11-20.
35. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277(5323):225-228.
36. Koshikawa N., Minegishi T., Sharabi A., Quaranta V., Seiki M. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J Biol Chem 2005, 280(1):88-93.
37. Carson A.E., Barker T.H. Emerging concepts in engineering extracellular matrix variants for directing cell phenotype. Regen Med 2009, 4(4):593-600.
38. Knight C.G., Morton L.F., Onley D.J., Peachey A.R., Messent A.J., Smethurst P.A., et al. Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem 1998, 273(50):33287-33294.
39. Knight C.G., Morton L.F., Peachey A.R., Tuckwell D.S., Farndale R.W., Barnes M.J. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 2000, 275(1):35-40.
40. Reyes C.D., Garcia A.J. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A 2004, 69(4):591-600.
41. Leu S.J., Liu Y., Chen N., Chen C.C., Lam S.C., Lau L.F. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J Biol Chem 2003, 278(36):33801-33808.
42. Yokosaki Y., Matsuura N., Higashiyama S., Murakami I., Obara M., Yamakido M., et al. Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem 1998, 273(19):11423-11428.
43. Lee S.T., Yun J.I., Jo Y.S., Mochizuki M., van der Vlies A.J., Kontos S., et al. Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials 2010, 31(6):1219-1226.